Structures by: Miao F.
Total: 10
C13.50H11B0.50FNO0.50
C13.50H11B0.50FNO0.50
Organic & biomolecular chemistry (2017) 15, 15 3188-3191
a=15.1844(5)Å b=20.7250(6)Å c=6.8775(2)Å
α=90° β=100.9610(10)° γ=90°
C31.25H29.5BCl0.5F2N2O4
C31.25H29.5BCl0.5F2N2O4
Organic & biomolecular chemistry (2017) 15, 15 3188-3191
a=8.3338(9)Å b=12.5679(14)Å c=14.0639(16)Å
α=87.509(5)° β=81.274(5)° γ=75.494(5)°
C48H64.61NO2
C48H64.61NO2
Chemical communications (Cambridge, England) (2020) 56, 38 5143-5146
a=12.1364(3)Å b=17.5731(4)Å c=22.0778(4)Å
α=90° β=92.7639(17)° γ=90°
C68H92N12O4S4
C68H92N12O4S4
RSC Adv. (2013) 3, 4 1029
a=13.9744(4)Å b=14.0021(4)Å c=19.6538(8)Å
α=72.1230(10)° β=81.2730(10)° γ=79.9070(10)°
4-{[3,4-Dihydro-5-methyl-3-oxo-2-phenyl-2H-pyrazol-4- ylidene](phenyl)methylamino}-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one
C28H25N5O2
Acta Crystallographica Section E (2003) 59, 4 o430-o432
a=6.986(3)Å b=27.904(11)Å c=12.804(5)Å
α=90.00° β=104.127(8)° γ=90.00°
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenylpyrazol-4-ylimino)-4,4,4-trifluoro- 1-(2-thienyl)butane-1,2-dione
C19H14F3N3O3S1
Acta Crystallographica Section E (2002) 58, 4 o385-o387
a=10.964(3)Å b=12.570(3)Å c=13.840(4)Å
α=90.00° β=96.822(5)° γ=90.00°
4-[(2-Hydroxyphenylamino)phenylmethylene]-5-methyl-2-phenyl-2H-pyrazol-3(4H)- one
C23H19N3O2
Acta Crystallographica Section E (2002) 58, 12 o1365-o1366
a=7.267(4)Å b=11.150(6)Å c=13.822(8)Å
α=111.794(9)° β=92.210(11)° γ=105.987(10)°
C19H16F3N3O2S
C19H16F3N3O2S
Acta Crystallographica Section E (2002) 58, 11 o1182-o1184
a=5.8063(10)Å b=10.9254(17)Å c=15.288(2)Å
α=74.790(3)° β=97.463(3)° γ=94.731(4)°
C50H42Cu1N6O5
C50H42Cu1N6O5
Acta Crystallographica Section E (2003) 59, 3 m128-m130
a=22.652(6)Å b=16.228(5)Å c=15.250(5)Å
α=90.00° β=130.636(14)° γ=90.00°
(<i>E</i>)-3-[2,5-Dioxo-3-(propan-2-ylidene)pyrrolidin-1-yl]acrylic acid
C10H11NO4
Acta Crystallographica Section E (2010) 66, 3 o634
a=6.5384(14)Å b=7.5309(17)Å c=10.405(2)Å
α=93.009(3)° β=101.247(2)° γ=90.410(3)°